Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q39455254)
Watch
English
Meloxicam: selective COX-2 inhibition in clinical practice
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
review article
1 reference
stated in
Europe PubMed Central
title
Meloxicam: selective COX-2 inhibition in clinical practice
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
main subject
meloxicam
1 reference
stated in
ChEBI release 2020-05-28
ChEBI ID
6741
author name string
D E Furst
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
publication date
1 June 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
published in
Seminars in Arthritis and Rheumatism
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
volume
26
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
page(s)
21-27
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
issue
6 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
cites work
Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of meloxicam: a global analysis of clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety evaluation of nabumetone in United States clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meloxicam: metabolic profile and biotransformation products in the rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of the clinical pharmacokinetics of meloxicam
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of etodolac administration on renal function in patients with arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980049-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0049-0172(97)80049-2
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
PubMed ID
9219316
1 reference
stated in
Europe PubMed Central
PubMed ID
9219316
retrieved
12 September 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
